End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Determination In-vivo KUF for Diacap Pro Hemodialyser [NA]
This update reports the completion of a clinical trial evaluating the in-vivo ultrafiltration performance (KUF) of the Diacap Pro Hemodialys…
-
CLINICAL_TRIALS safety_alert · 2017-01-27Clinical Trial Update: Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients
Post-marketing safety surveillance update assessing adverse events of Kiklin capsules in chronic kidney disease patients on hemodialysis wit…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease [Phase 2]
Phase 2 clinical trial evaluating growth hormone treatment in adult patients with chronic kidney disease, including end-stage renal disease,…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis [Phase 1]
This completed Phase 1 trial evaluated the pharmacokinetics of somatropin in patients with end-stage renal disease on chronic haemodialysis.…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis [Phase 1]
A Phase 1 pharmacokinetic, pharmacodynamic, and safety study evaluating a single dose of rivaroxaban in adults with end-stage renal disease …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-01-24Clinical Trial Update: Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating different doses of oral melatonin for sleep disorders in patients wi…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients [Phase 3]
Phase 3 trial evaluating Mircera (methoxy polyethylene glycol-epoetin beta) for maintenance treatment of anemia in dialysis patients has com…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Effects of Dexmedetomidine on Postoperative Renal Function Recovery After Kidney Transplantation in Adult Patients [NA]
This document provides an update on a clinical trial evaluating whether dexmedetomidine improves postoperative renal function recovery after…
-
CLINICAL_TRIALS research · 2017-01-19Clinical Trial Update: Food Preparation Effects on Gut Bacteria in Patients on Peritoneal Dialysis [NA]
A completed clinical trial investigates how food preparation affects gut bacteria in patients with end-stage renal disease undergoing perito…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: The Impact of Magnesium Supplementation on Insulin Resistance and Secretion in Renal Transplant Recipients [NA]
This completed trial evaluated whether magnesium supplementation affects insulin resistance and insulin secretion in renal transplant recipi…
-
CLINICAL_TRIALS research · 2017-01-18Clinical Trial Update: Intravenous Paricalcitol in Chronic Hemodialysis Patients [Phase 4]
Phase 4 clinical trial update for intravenous paricalcitol in chronic hemodialysis patients; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Mid-HDF Randomized Controlled Study on Outcome [NA]
Update on the outcomes of a Mid-HDF randomized controlled study in patients with End-Stage Renal Disease.
-
CLINICAL_TRIALS withdrawal · 2017-01-12Clinical Trial Update: Assessment of a Follow-up With Tele-consulting for Patients With Renal Failure Under Peritoneal Dialysis
The clinical trial evaluating tele-consultations for patients with chronic kidney disease on peritoneal dialysis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens [Phase 3]
This Phase 3 trial completed evaluating whether intravenous gamma globulin improves kidney transplant survival in highly sensitized patients…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10% [Phase 2]
A Phase 2 study evaluating intravenous immunoglobulin (IGIV-C) 10% to improve transplant options for highly sensitized recipients with chron…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Inspiratory Muscle Training in Patients With End-stage Renal Disease [NA]
A clinical trial evaluating inspiratory muscle training in patients with end-stage renal disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Epidemiologic Study and Impact Study of a Dialysis Solution Change on the Electrocardiographic Profile of Patient
Completed clinical trial evaluating the impact of changing the dialysis solution on the electrocardiographic profile of patients undergoing …
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients [NA]
This clinical trial update reports that the study of a peroxisome proliferator-activated receptor-gamma agonist in diabetic patients with en…
-
CLINICAL_TRIALS withdrawal · 2017-01-09Clinical Trial Update: Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring [Phase 4]
A Phase 4 trial investigating cardiovascular risk after converting kidney transplant recipients to full-dose Myfortic and Neoral with two-ho…
-
FDA approval · 2016-12-16FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for EXTRANEAL (icodextrin) from Vantive US Healthcare LLC.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Trace Element Replenishment Study in Hemodialysis Patients [Phase 3]
Phase 3 trial evaluating trace element replenishment in patients undergoing hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis [Phase 2]
Phase 2 trial update on safety, pharmacokinetics, and pharmacodynamics of ISIS 416858 administered subcutaneously to patients with end-stage…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Glycaemic Response to Oral Nutrition Support During Haemodialysis [NA]
This completed clinical trial evaluates glycaemic response to oral nutrition support during haemodialysis in individuals with diabetes and k…
-
FDA approval · 2016-12-09FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution. The formulation contains sodi…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Examining the Impact of Using Two Dialysers in Parallel on Dialysis Adequacy in Hemodialysis Patients [NA]
A completed clinical trial evaluated whether using two dialyzers in parallel improves dialysis adequacy in patients with end-stage renal dis…